Optical imaging firm submits application

Imaging Diagnostic Systems has submitted the last of five modules to the FDA as part of an effort to win approval to market an optical imaging system that visualizes the blood supply to breast tumors. The system, called Computed Tomography Laser Mammography (CTLM), is designed as an adjunct to x-ray mammography for women who have dense breasts and equivocal mammograms, adding information to guide biopsy recommendations. Clinical studies of the technology began six years ago (SCAN 2/19/97).